Scholar Rock Holding Corp - Common Stock, par value $0.001 per share (SRRK)

CUSIP: 80706P103

Q2 2026 13F Holders as of 30 Jun 2026

Holder snapshot 7 signals
Share change
+5,921,651
Put/Call ratio
155%
SEC-reported price per share
$55.00
Number of holders
304
Value change
+$349,449,529
Number of buys
183
Open additional details 1 more signal available
Number of sells
104
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
119,752,556

Security key

80706P103

Report period

Q2 2026

Institutions

304

Top holders

10

Ownership snapshot

Top reported holders of SRRK - Scholar Rock Holding Corp - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
FMR LLC
Disclosed value leader
FMR LLC
Comparable rows
15/15
Latest evidence
30 Jun 2026
13F 13D/G 3/4/5 Lead comparable stake: 15% 13D/G row: FMR LLC Showing 1-6 of 15 holder rows.

Quick read

FMR LLC leads the comparable SEC ownership view at 15%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens FMR LLC's linked filing trail.
Comparable ownership Top 5
FMR LLC 15%
Invus Global Management, LLC 8%
Samsara BioCapital, L.P. 7.2%
WELLINGTON MANAGEMENT GROUP LLP 5.6%
PRICE T ROWE ASSOCIATES INC /MD/ 5.4%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
FMR LLC
13F 13D/G
Company
15%
from 13D/G
$847,673,353
17,243,152 shares
31 Mar 2026
Invus Global Management, LLC
13D/G 3/4/5
Invus Public Equities, L.P. · 10%+ Owner
8%
$526,625,715
9,575,013 shares
-$68,750,000 30 Jun 2026
Samsara BioCapital, L.P.
13D/G
Srinivas Akkaraju
7.2%
$260,368,230
6,991,553 shares
$0 03 Oct 2025
WELLINGTON MANAGEMENT GROUP LLP
13F 13D/G
Company
5.6%
from 13D/G
$330,239,920
6,717,655 shares
31 Mar 2026
PRICE T ROWE ASSOCIATES INC /MD/
13F 13D/G
Company · T. Rowe Price Associates, Inc.
5.4%
from 13D/G
$305,119,000
6,206,618 shares
31 Mar 2026
Redmile Group, LLC
13F 13D/G
Company
3.6%
from 13D/G
$445,715,088
9,066,621 shares
31 Mar 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
304
Shares
138,629,974
Rows available
304
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2026 vs Q1 2026 Across Filers

Q1 2026 holders
273
Q2 2026 holders
304
Holder diff
31
Investor Q1 2026 Shares Q2 2026 Shares Share Diff Share Chg % Q1 2026 value Q2 2026 value Value change Value Chg %
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .